Items tagged with Guidelines

U.S. guidelines recommend newer tests to diagnose TB (post)

ARLINGTON, Va., December 8 – Patients at risk for latent or active tuberculosis (TB) infection should be assessed with newer tests, including interferon-gamma release assays (IGRAs) and molecular diagnostics, recommend guidelines on TB diagnosis developed by the American Thoracic Society (ATS), Infectious Diseases Society of America (IDSA) and Centers for Disease Control and Prevention (CDC) and published in the journal Clinical Infectious Diseases. Advances in testing prompted the first new guidelines on TB diagnosis in 17 years.

Pediatric tuberculosis in Canada: A guide for physicians (post)

Although pediatric tuberculosis (TB) remains relatively uncommon in Canada, some populations -- including Aboriginal communities -- have a much higher burden of disease. As a result, Canada should focus on addressing the high rates of the disease in these communities, according to a review in CMAJ (Canadian Medical Association Journal),

China issues guideline on TB prevention, treatment (post)

BEIJING, Feb. 16 (Xinhua) -- China's central government has issued a guideline on the prevention and treatment of tuberculosis.

DR-TB STAT on WHO bedaquiline recommendations (post)

The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) issued a Bedaquiline Bulletin.

Groundbreaking guide on community-based HIV prevention services launched in Cape Town (post)

A groundbreaking guide aimed at helping people to set up community-based HIV prevention services has been launched in Cape Town.

Legal environment assessments for TB: an operational guide tool (post)

Human rights violations continue to be a barrier to accessing TB prevention, diagnosis and treatment services for many marginalized groups such as prisoners, miners and immigrants. The Stop TB Partnership collaborated with UNDP to develop the Guide, which will help civil society and government to address legal and policy barriers and opportunities to increase access to TB health services. 

WHO to review its interim guidance on the use of delamanid in the treatment of multidrug-resistant TB following the release of Phase III clinical trial results (post)

The World Health Organization (WHO) has started preparations for a rapid review of its interim guidance on the use of delamanid in the treatment of patients with multidrug-resistant tuberculosis (MDR-TB). This follows the release of the phase III randomised control trial results by Otsuka Pharmaceutical at the 48th Union World Conference on Lung Health on 13 October.

Guide to delivering high quality care for TB patients launched (post)

12 December 2017 - Today on Universal Health Coverage Day, The International Union Against Tuberculosis and Lung Disease (The Union) and the International Council of Nurses (ICN) have launched updated guidance for health care workers who are involved in detecting and caring for patients with tuberculosis (TB).

South African National Tuberculosis Management Guidelines (document)

The guidelines formally introduce targeted screening to increase detection of TB cases, guidance for the use of GeneXpert and revised treatment regimens for retreatment patients. The 120-document also includes guidance on the management of adverse drug events and antiretroviral initiation for patients co-infected with HIV.

Guidelines for the management of tuberculosis in children (document)

The guidelines outline care and treatment for children with tuberculosis (TB) in South Africa, include better guidance on dosing children with TB in the absence of widely available paediatric formulations including changes to the recommended doses for some drugs and sections on TB diagnosis in HIV-infected children, TB preventative treatment and nutritional support.

Page 2 of 5 · Total posts: 0

←First 1 2 3 Last→